Wiseman, Hailey (2020) Using measures of corticospinal excitability to map symptom severity in multiple sclerosis. Masters thesis, Memorial University of Newfoundland.
[English]
PDF
- Accepted Version
Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission. Download (1MB) |
Abstract
Background: Transcranial magnetic stimulation (TMS) is a tool used to measure corticospinal excitability. To evaluate the usefulness of TMS as a biomarker in multiple sclerosis (MS), the first step is to examine how well variables derived using TMS align with clinical symptoms of MS. Methods: Participants with MS (n=38) were assigned to motor, cognitive, sensory, or asymptomatic clinical group based on their Expanded Disability Status Scale (EDSS) assessment. Following recording of demographic information, subjective health and scoring of walking and cognition, TMS measures were collected from each brain hemisphere. We first examined whether TMS parameters (resting motor threshold (RMT), active motor threshold (AMT), and cortical silent period (CSP)) would differ among clinical groups. Next, we examined whether TMS parameters predicted severity of symptoms. Results: CSP and AMT in the hemisphere corresponding to the weaker hand predicted measures of symptom severity among people with MS in the motor and cognitive profile groups. Longer CSP was the strongest predictor of slower walking speed (F(1,17)=22.82, p<0.001). Higher AMT was the strongest predictor of cognitive impairment using the Montreal Cognitive Assessment (F(1,17)==25.29, p=0.001) and perceived physical impact of MS using the Multiple Sclerosis Impact Scale-29 (F(1,17)=30.63, p<0.001). Conclusions: CSP and AMT in the hemisphere corresponding to the weaker hand predicted severity of symptoms among people with MS in the motor and cognitive groups. In these cases, TMS variables provided greater predictive value than the traditional EDSS, supporting the use of TMS outcomes as biomarkers in MS.
Item Type: | Thesis (Masters) |
---|---|
URI: | http://research.library.mun.ca/id/eprint/14384 |
Item ID: | 14384 |
Additional Information: | Includes bibliographical references (pages 82-108). |
Keywords: | TMS, Biomarker, CSP, AMT |
Department(s): | Medicine, Faculty of > Biomedical Sciences |
Date: | May 2020 |
Date Type: | Submission |
Digital Object Identifier (DOI): | https://doi.org/10.48336/phgz-5t58 |
Medical Subject Heading: | Multiple Sclerosis; Transcranial Magnetic Stimulation. |
Actions (login required)
View Item |